Tesla's pullback misses the real debate. TSLA at $382.45 and a $1.44 trillion market cap is no longer a stock the market values on quarterly EV noise alone; it is being underwritten as an autonomy platform, and the June 3 expansion of unsupervised robotaxis across the entire Austin metro area is the proof point keeping that narrative intact. That does not make the valuation sane by traditional auto standards, but it does explain why traditional auto comparisons keep failing. The right question here is not whether Tesla looks expensive next to Ford or Toyota on today's earnings, but whether robotaxi progress is enough to justify the market's willingness to look far beyond them.
The simplest evidence is in the multiple itself. TSLA trades at 315.72 times trailing earnings and 14.58 times sales, while Toyota sits at 9.11 times earnings and 0.63 times sales and Ford at 0.29 times sales. A company with revenue shrinking 2.9% year over year and EPS down 47.1% does not earn that kind of gap by being a better carmaker. The market is clearly assigning value to something else, and right now that something is autonomy.
The June 3 Austin update matters because it moved the story from promise to operating footprint. Tesla expanded unsupervised robotaxis across the entire Austin metro area, which is exactly the kind of milestone the market needs to keep treating the company as more than an EV manufacturer. That framing lines up with management's own push to present Tesla as a "physical AI company," and it helps explain why the stock can hold such a rich premium even with weak near-term fundamentals. If investors were focused mainly on the car business, TSLA's TickerSpark Score would be a much bigger problem: Overall 45, with a Valuation score of 32 and a Growth score of just 15.
There is also a reason the story has not fully broken despite ugly headline numbers. Tesla still carries a Financial Health score of 92, giving it room to fund long-duration bets that most automakers cannot. Recent earnings have at least stabilized at the margin too, with back-to-back quarterly EPS beats in April and January, even if the broader beat rate is only 3 out of 7. That combination matters: a financially strong company with a live autonomy rollout gets more market patience than a conventional automaker fighting for cyclical share.
The bulls do not get a free pass on execution. Profitability is thin for a company priced this aggressively, with a 5.0% operating margin and 4.0% net margin, and the safety overhang is real after the June 22 special investigation tied to a fatal Texas crash and the earlier engineering analysis of FSD. Add in reports of 14 Austin crash incidents over roughly eight months, and it is easy to see why plenty of investors refuse to pay platform multiples for what still looks like an early, fragile rollout.
The tape is not helping either. TSLA is below its 20-day, 50-day, and 200-day moving averages, momentum is weak with an RSI of 40.39, and the stock is down 13.2% year to date versus a 3.5% decline for Consumer Cyclical, a 9.7-point underperformance. Consensus is only Hold, with 34 holds against 32 buys and 15 sells, which tells you the Street is far from unified. Even so, that skepticism actually reinforces the setup: if robotaxi milestones were irrelevant, the stock would not still command 315.72 times earnings in the face of this much operational and regulatory noise.
That is why we'd rather own TSLA than F here, even with the valuation risk. Ford is easier to model, but Tesla still has the one thing Ford does not: a credible shot, however controversial, at being valued as an autonomy platform instead of a metal-bending manufacturer. The market has already told investors what matters most, and it is not whether next quarter's auto margins look a little better or worse.
The trigger to respect now is robotaxi follow-through. If Tesla keeps expanding beyond Austin and management reinforces deployment timelines around the expected July 22 earnings window, the autonomy underwriting stays alive and the recent pullback looks more like noise than thesis damage. If safety probes deepen or rollout milestones stall, the stock's weak TickerSpark Score on Valuation and Growth becomes much harder to ignore. This is not a stock for oversized positions, but the right read is still reframe, not retreat.
